Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.
暂无分享,去创建一个
A. Jemal | P. Gray | J. Efstathiou | C. Lin
[1] Roger. T. Anderson,et al. Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer , 2016, American journal of clinical oncology.
[2] T. Choueiri,et al. Income inequality and treatment of African American men with high-risk prostate cancer. , 2015, Urologic oncology.
[3] K. Bilimoria,et al. Comparing national cancer registries: The National Cancer Data Base (NCDB) and the surveillance, epidemiology, and end results (SEER) program , 2014, Journal of surgical oncology.
[4] E. Crawford,et al. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. , 2014, International journal of radiation oncology, biology, physics.
[5] T. Skolarus,et al. Regional variation in quality of prostate cancer care. , 2014, The Journal of urology.
[6] T. H. van der Kwast,et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. , 2014, European urology.
[7] M. Blute,et al. Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy. , 2013, Oncology.
[8] T. D. de Reijke,et al. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] Andrew Ma,et al. Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries , 2013, Annals of Surgical Oncology.
[10] M. Parmar,et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial , 2011, The Lancet.
[11] U. Capitanio,et al. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis. , 2011, European urology.
[12] C. L. Cutajar,et al. External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study. , 2010, The Lancet. Oncology.
[13] A. Jemal,et al. Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006 , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[14] Elizabeth E Ward,et al. The National Cancer Data Base: Past, Present, and Future , 2009, Annals of Surgical Oncology.
[15] C. Ko,et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] F. Fazio,et al. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. , 2009, European urology.
[17] S. Fosså,et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial , 2009, The Lancet.
[18] T. Jang,et al. Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. , 2007, International journal of radiation oncology, biology, physics.
[19] E. Bergstralh,et al. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. , 2007, The Journal of urology.
[20] D. Grignon,et al. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Jie Cai,et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. , 2004, The Journal of urology.
[22] John T. Wei,et al. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. , 2004, The Journal of urology.
[23] F. Burkhard,et al. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? , 2003, The Journal of urology.
[24] A. V. von Eschenbach,et al. Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer. , 2001, Urology.
[25] D. Bostwick,et al. Risk of prostate carcinoma death in patients with lymph node metastasis , 2001, Cancer.
[26] Lori S. Parsons. Reducing Bias in a Propensity Score Matched-Pair Sample Using Greedy Matching Techniques , 2001 .